The BCMM leads projects on early-life microbiome development and microbiome interactions with disease therapeutics.
PREMO: Premature Microbiome and Outcomes
PREMO is a collaborative project with the UCSF PROMPT study and the California Preterm Birth Initiative (PTBi-CA). It focuses on understanding how the microbiome in early life affects the development of preterm infants. The project's first steps included the development of a large and well-characterized cohort of preterm infants and the collection of detailed samples over time. This work has already contributed to predictive modeling efforts to better understand preterm birth.
Learn more about the PREMO Initiative.
Therapeutics
The BCMM is studying how medicines, including small molecules and biologics, affect differences in microbiome structure and function between individuals. The goal is to repurpose existing drugs and create new treatments based on microbes to help manage inflammatory diseases.